Please use this identifier to cite or link to this item: http://ahro.austin.org.au/austinjspui/handle/1/13730
Full metadata record
DC FieldValueLanguage
dc.contributor.authorGrossmann, Mathis-
dc.contributor.authorCheung, Ada S-
dc.date2016-01-27-
dc.date.accessioned2016-02-03T05:47:53Z-
dc.date.accessioned2016-02-03T05:50:12Z-
dc.date.available2016-02-03T05:47:53Z-
dc.date.available2016-02-03T05:50:12Z-
dc.date.issued2016-
dc.identifier.citationEuropean urology 2016; 69(6): 1161-2en_US
dc.identifier.urihttp://ahro.austin.org.au/austinjspui/handle/1/13730-
dc.subjectAntineoplastic Agents, Hormonal/therapeutic useen_US
dc.subjectPhysical Fitnessen_US
dc.titleImpact of androgen deprivation therapy on high-level physical performanceen_US
dc.typeLetteren_US
dc.identifier.journaltitleEuropean Urologyen_US
dc.identifier.affiliationDepartment of Medicine, The University of Melbourne, Austin Health, Heidelberg, Victoria, Australia-
dc.identifier.pubmedurihttp://www.ncbi.nlm.nih.gov/pubmed/26827095en_US
dc.identifier.doi10.1016/j.eururo.2016.01.025en_US
dc.type.contentTexten_US
dc.identifier.orcid0000-0001-5257-5525-
Appears in Collections:Journal articles

Files in This Item:
There are no files associated with this item.


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.